PURE Bioscience, Inc. (PURE)
| Market Cap | 17.12M |
| Revenue (ttm) | 1.96M |
| Net Income (ttm) | -3.35M |
| Shares Out | 111.86M |
| EPS (ttm) | -0.03 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 11,700 |
| Open | 0.160 |
| Previous Close | 0.160 |
| Day's Range | 0.160 - 0.160 |
| 52-Week Range | 0.060 - 0.170 |
| Beta | 0.06 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 28, 2024 |
About PURE Bioscience
PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. Its technology platform contains silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. The company offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a ready-to-use hard surface disinfectant and food contact surfa... [Read more]
Financial Performance
In 2024, PURE Bioscience's revenue was $1.96 million, an increase of 4.58% compared to the previous year's $1.88 million. Losses were -$3.35 million, -15.43% less than in 2023.
Financial StatementsNews
PURE Bioscience Announces Distribution Agreement with Quip Laboratories
EL CAJON, Calif.--(BUSINESS WIRE)-- #AALAS--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, and Qu...
PURE Bioscience Reports Fiscal 2024 Financial Results
EL CAJON, Calif.--(BUSINESS WIRE)-- #Biofilm--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, toda...
PURE Bioscience Announces Distribution Agreement with Madison Chemical Co., Inc.
EL CAJON, Calif.--(BUSINESS WIRE)-- #Antimicrobial--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial...
PURE Bioscience Announces Distribution Agreement with Zee Company
EL CAJON, Calif.--(BUSINESS WIRE)-- #Biofilm--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), has entered into a multi-year distribution agreement with Tennessee-based Zee Company...
PURE Bioscience Announces Distribution Agreement with ChemStation
EL CAJON, Calif.--(BUSINESS WIRE)-- #Biofilm--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, and ...
PURE Bioscience to Unveil its Newest Food Safety Solutions at the Annual International Association for Food Protection Meeting
EL CAJON, Calif.--(BUSINESS WIRE)-- #Biofilm--PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, is set to unveil its newest food saf...
PURE Bioscience Announces an International Supply and License Agreement with AgroVet Alliance
EL CAJON, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, and AgroVet All...
PURE Bioscience Reports Fiscal Third Quarter 2024 Financial Results
EL CAJON, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported ...
PURE Bioscience Appoints Darin Zehr to Board of Directors
EL CAJON, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported ...
PURE Bioscience Reports Fiscal Second Quarter 2024 Financial Results
EL CAJON, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported ...
PURE Bioscience Reports Fiscal First Quarter 2024 Financial Results
EL CAJON, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported ...
PURE Bioscience Reports Fiscal 2023 Financial Results
EL CAJON, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported ...
PURE Bioscience to unveil “PURE Genius” Food Safety Program at the Annual International Association for Food Protection Meeting
RANCHO CUCAMONGA, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, is set to unveil its “PURE Genius” food...
PURE Bioscience Reports Fiscal 2023 Third Quarter And Nine-Month Financial Results
RANCHO CUCAMONGA, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for th...
PURE Bioscience Reports Fiscal 2023 Second Quarter And Six-Month Financial Results
RANCHO CUCAMONGA, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for th...
PURE Bioscience Reports Fiscal First Quarter 2023 Financial Results
RANCHO CUCAMONGA, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today...
Hydrite Named Exclusive Distributor for PURE Bioscience in Dairy and Plant-Based Protein Market
BROOKFIELD, Wis. , Nov. 2, 2022 /PRNewswire/ -- Hydrite has entered into a multi-year agreement with PURE Bioscience, Inc. (OTCQB: PURE) to be the exclusive distributor of PURE® Hard Surface disinfect...
PURE Bioscience Reports Fiscal 2022 Financial Results
RANCHO CUCAMONGA, Calif.
PURE Bioscience Reports Fiscal 2022 Third Quarter and Nine-Month Financial Results
RANCHO CUCAMONGA, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for th...
PURE Bioscience Reports Fiscal 2022 Second Quarter And Six-Month Financial Results
RANCHO CUCAMONGA, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for th...
PURE Bioscience Reports Fiscal First Quarter 2022 Financial Results
RANCHO CUCAMONGA, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE) (the “Company,” “PURE” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today r...
PURE Bioscience Reports Fiscal 2021 Third Quarter and Nine-Month Financial Results
RANCHO CUCAMONGA, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE) (the “Company,” “PURE” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today r...
PURE Bioscience Reports Fiscal 2021 Second Quarter And Six-Month Financial Results
RANCHO CUCAMONGA, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for th...